If you have any question, please feel free to email us. We will touch with you as soon as possible.
CAS:84057-84-1
Source:Poland
Qualifications:-/CEP/-/-/-
Name | Lamotrigine |
---|---|
Chinese name | 拉莫三嗪 |
Cas Number | 84057-84-1 |
Source | Poland |
Qualifications | -/CEP/-/-/- |
Lamotrigine is a voltage-based sodium ion channel blocker, which can inhibit pathological glutamate release and also inhibit the burst of glutamate-induced action potentials. It was approved by the FDA in 1994 for partial seizures And primary and secondary generalized tonic-clonic seizures monotherapy or other adjuvant treatments for epilepsy. Compared with other anti-epileptic drugs, it has the advantages of broad-spectrum anti-epileptic, high bioavailability, long half-life, rapid oral absorption, fewer side effects, and non-hepatic enzyme inducers have no effect on other drugs. Global sales in 2016 were 614 million pounds, a 16% increase from 2015.
Hot Tags: lamotrigine api, China, suppliers, manufacturers, factory, customized, price, pricelist, in stock, Tetrabenazine API, Bemeprost API, Gabapentin API, Valganciclovir Hydrochloride API, Oseltamivir Phosphate API, Aprepitant Aprepitant API
Tel:+86-020-61855200-902
Fax:+86-020-66392525
Email:info@upharm.cn
Address:12th floor, No. 181, Kexue Avenue, Huangpu District, Guangzhou, China